Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03244384 |
|---|---|
| Brief Title: | Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer (AMBASSADOR) |
| First Submitted : | August 7, 2017 |
| First Submitted that Met QC Criteria : | August 8, 2017 |
| First Posted : | August 9, 2017 |
| Last Update Submitted that Met QC Criteria : | May 16, 2024 |
| Last Update Posted : | May 20, 2024 (Estimate) |